An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods

Unlike organic molecules, reports on docking of metal complexes are very few; mainly due to the inadequacy of force fields in docking packages to appropriately characterize the metal atoms that consequentially hinder the rational design of metal-based drug complexes. In this study we have made used...

Full description

Bibliographic Details
Main Authors: Peter A. Ajibade, Adebayo A. Adeniyi
Format: Article
Language:English
Published: MDPI AG 2013-09-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/18/9/10829
_version_ 1831683102837047296
author Peter A. Ajibade
Adebayo A. Adeniyi
author_facet Peter A. Ajibade
Adebayo A. Adeniyi
author_sort Peter A. Ajibade
collection DOAJ
description Unlike organic molecules, reports on docking of metal complexes are very few; mainly due to the inadequacy of force fields in docking packages to appropriately characterize the metal atoms that consequentially hinder the rational design of metal-based drug complexes. In this study we have made used Molegro and Autodock to predict the anticancer activities of selected Ru(II) complexes against twelve anticancer targets. We observed that introducing the quantum calculated atomic charges of the optimized geometries significantly improved the docking predictions of these anticancer metallocompounds. Despite several limitations in the docking of metal-based complexes, we obtained results that are highly correlated with the available experimental results. Most of our newly proposed metallocompounds are found theoretically to be better anticancer metallocompounds than all the experimentally proposed RAPTA complexes. An interesting features of a strong interactions of new modeled of metallocompounds against the two base edges of DNA strands suggest similar mechanisms of anticancer activities similar to that of cisplatin. There is possibility of covalent bonding between the metal center of the metallocompounds and the residues of the receptors DNA-1, DNA-2, HDAC7, HIS and RNR. However, the general results suggest the possibility of metals positioning the coordinated ligands in the right position for optimal receptor interactions and synergistic effects, rather than forming covalent bonds.
first_indexed 2024-12-20T06:31:31Z
format Article
id doaj.art-470f2763b7384516bdbe60b56edf1d16
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-20T06:31:31Z
publishDate 2013-09-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-470f2763b7384516bdbe60b56edf1d162022-12-21T19:50:07ZengMDPI AGMolecules1420-30492013-09-01189108291085610.3390/molecules180910829An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking MethodsPeter A. AjibadeAdebayo A. AdeniyiUnlike organic molecules, reports on docking of metal complexes are very few; mainly due to the inadequacy of force fields in docking packages to appropriately characterize the metal atoms that consequentially hinder the rational design of metal-based drug complexes. In this study we have made used Molegro and Autodock to predict the anticancer activities of selected Ru(II) complexes against twelve anticancer targets. We observed that introducing the quantum calculated atomic charges of the optimized geometries significantly improved the docking predictions of these anticancer metallocompounds. Despite several limitations in the docking of metal-based complexes, we obtained results that are highly correlated with the available experimental results. Most of our newly proposed metallocompounds are found theoretically to be better anticancer metallocompounds than all the experimentally proposed RAPTA complexes. An interesting features of a strong interactions of new modeled of metallocompounds against the two base edges of DNA strands suggest similar mechanisms of anticancer activities similar to that of cisplatin. There is possibility of covalent bonding between the metal center of the metallocompounds and the residues of the receptors DNA-1, DNA-2, HDAC7, HIS and RNR. However, the general results suggest the possibility of metals positioning the coordinated ligands in the right position for optimal receptor interactions and synergistic effects, rather than forming covalent bonds.http://www.mdpi.com/1420-3049/18/9/10829ruthenium complexesanticancerdocking methodsreceptors
spellingShingle Peter A. Ajibade
Adebayo A. Adeniyi
An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
Molecules
ruthenium complexes
anticancer
docking methods
receptors
title An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
title_full An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
title_fullStr An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
title_full_unstemmed An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
title_short An Insight into the Anticancer Activities of Ru(II)-Based Metallocompounds Using Docking Methods
title_sort insight into the anticancer activities of ru ii based metallocompounds using docking methods
topic ruthenium complexes
anticancer
docking methods
receptors
url http://www.mdpi.com/1420-3049/18/9/10829
work_keys_str_mv AT peteraajibade aninsightintotheanticanceractivitiesofruiibasedmetallocompoundsusingdockingmethods
AT adebayoaadeniyi aninsightintotheanticanceractivitiesofruiibasedmetallocompoundsusingdockingmethods
AT peteraajibade insightintotheanticanceractivitiesofruiibasedmetallocompoundsusingdockingmethods
AT adebayoaadeniyi insightintotheanticanceractivitiesofruiibasedmetallocompoundsusingdockingmethods